Reporting owner · Q3 2026 · CIK 2030840

Heltzen Michael: insider trades.

Heltzen Michael reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 5 open-market purchases ($6K) and 0 sales, across 1 company.

Transactions
6
Purchases (P)
5
Sales (S)
0
Companies
1
Name as filed
Heltzen Michael

Companies

CompanyRelationshipTransactions
Exozymes Inc. (EXOZ)Officer · Chief Executive Officer6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-26Exozymes Inc.P251$7.3514,704Form 4
2026-08-26Exozymes Inc.P250$7.614,453Form 4
2026-08-26Exozymes Inc.P4$7.5814,708Form 4
2026-08-25Exozymes Inc.P100$7.513,953Form 4
2026-08-25Exozymes Inc.P250$7.5214,203Form 4
2026-08-19Exozymes Inc.A8,841$6.413,853Form 4

Questions

What stock did Heltzen Michael buy or sell?

Heltzen Michael reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 5 open-market purchases ($6K) and 0 sales, across 1 company.

Is Heltzen Michael the same person as other filers with this name?

This page covers SEC CIK 2030840 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/heltzen-michael-2030840.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.